Prostate Cancer
Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract
September 16, 2011
Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract
September 16, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy - Abstract
September 16, 2011
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract
September 16, 2011
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone - Abstract
September 16, 2011
Gleason score 7 prostate cancer on needle biopsy: Relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy - Abstract
September 15, 2011
Emerging therapies to prevent skeletal morbidity in men with prostate cancer - Abstract
September 15, 2011
Construct validity in a high-fidelity prostate exam simulator - Abstract
September 15, 2011
Role of pelvic lymph node dissection in prostate cancer treatment - Abstract
September 15, 2011
Active-targeted nanotherapy strategies for prostate cancer - Abstract
September 15, 2011
Transrectal implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT - Abstract
September 14, 2011
T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy - Abstract
September 14, 2011
Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates - Abstract
September 14, 2011
Determination of action thresholds for electromagnetic tracking system-guided hypofractionated prostate radiotherapy using volumetric modulated arc therapy - Abstract
September 14, 2011
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer - Abstract
September 14, 2011